INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Afton Scientific Capabilities Update January 2026: Fill/Finish
Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
-
Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems
Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.
-
Enhancing Biopharmaceutical Production Through Advanced Mixing
Eliminate particulate contamination and product degradation in downstream bioprocessing. Learn how frictionless, levitating impeller technology ensures low-shear mixing and high yields.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies3/20/2026
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
Water For Injection: Strategic Utility And The Case For Outsourcing3/9/2026
Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.
-
The Rise In Aseptic Manufacturing Solutions With Smaller Footprints2/19/2025
Aseptic drug manufacturing is going small. Discover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.
-
Effective Strategies To Minimize Product Loss During Fill Finish5/11/2026
Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.
-
Maximize Your Drug Product Recovery With A Complete Fill Finish Solution5/29/2025
Discover how to maximize drug product recovery with an end-to-end fill-finish solution. Get excellent integrity assurance and exceptional lead times for your critical processes.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Ensure sterile compliance and safety by understanding proper airflow and pressure dynamics in your compounding workflow. Choose the right hardware for your facility.
-
Modular aseptic isolation combines sterility assurance, rapid bio-decontamination, glove and chamber leak testing, and validation-ready controls to support safer pharmaceutical and biotech production.
-
If you are looking for filling systems for different products such as liquids, powder or flow-resistant highly viscous materials, Dec provides a modular concept allowing to meet a variety of packaging that is appropriate in the field of research and development as well as clinical trials. Speed up your go-to-market strategy with innovation and modular thinking.
-
Containment is a major concern for GMP industries. With a proven track record in managing highly technical and challenging isolation projects Dec is the perfect partner for the integration of new or existing equipment by providing comprehensive safe, ergonomic and dedicated containment solutions.
-
- Advanced Technology
- Laboratory, stability/clinical trial, 503b, vaccine, biologic, small scale production capable Blow/Fill/Seal system
- Extremely versatile, small-footprint machine
- Single-Use Technology (SUT) or CIP/SIP configuration
- All Electric-Servo motion controls
- Stepped-base design for easy maintenance and changeover